MedTrace Logo

Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative Joint Replacements

NCT00958945 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2009-08-14

No results posted yet for this study

Summary

The purpose of this analysis is to compare Hemoglobin and Hematocrit levels following total hip or knee arthroplasty. The utilization of FloSeal intraoperatively will improve hemostasis postoperatively. Decreasing bleeding time will decrease the drop in level of Hemoglobin and Hematocrit which usually occurs postoperatively.

Conditions

  • Total Knee Arthroplasty
  • Arthroplasty, Replacement, Hip

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Desert Orthopedic Center Medical Research Foundation

    lead OTHER

Principal Investigators

  • John H. Velyvis,, MD · Desert Orthopedic Center

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00958945 on ClinicalTrials.gov